Home > Products > CD28 & CD40
> Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (scIgG)
Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (scIgG) (CAT#: SCIGG-056)
Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD28 and anti-CD40 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can increase T-cell proliferation, induce DC maturation and prime efficacy of cytotoxic T cells. It is designed for the research of Acute myeloid leukaemic (AML) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (scIgG) (SCIGG-056). Click the button below to contact us or submit your feedback about this product.